You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CYTARABINE (ARA-C)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Leukemia Trial in Tianjin (DNR:, Ara-c)

Completed
Has Results
  • Leukemia
  • Tianjin, Tianjin, China
  • +1 more
Aug 8, 2021

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)

    Completed
    • Leukemia
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Sep 30, 2022

    Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia

    Completed
    Has Results
    • Acute Lymphoblastic Leukemia
    • Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
    • Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jul 26, 2022

    Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Gilteritinib 40 MG Oral Tablet
    • +4 more
    • Lexington, Kentucky
      University of Kentucky
    Oct 27, 2022

    Lymphoblastic Leukemia in Children Trial (induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal

    Not yet recruiting
    • Lymphoblastic Leukemia in Children
    • induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
    • +7 more
    • (no location specified)
    Oct 24, 2023

    Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

    Recruiting
    • Hematological Malignancy
    • Ningbo, Zhejiang, China
      The Affiliated People's Hospital of Ningbo University.
    Aug 18, 2022

    Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Newcastle (Bisantrene DiHCl

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Bisantrene Dihydrochloride (high dose)
    • +3 more
    • Newcastle, New South Wales, Australia
      Calvary Mater
    Jul 14, 2022

    Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)

    Not yet recruiting
    • Thrombotic Disorder
    • (no location specified)
    Jun 8, 2023

    Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

    Not yet recruiting
    • Leukemia, Acute Myeloid (AML)
    • (no location specified)
    Oct 16, 2022

    Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

    Recruiting
    • Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Aug 23, 2022

    Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)

    Not yet recruiting
    • Leukemia, Juvenile Myelomonocytic
    • +4 more
    • (no location specified)
    May 4, 2023

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Tumor, Acute Myeloid

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • (no location specified)
    Nov 15, 2022

    Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

    Recruiting
    • Relapsed or Refractory Acute Myeloid Leukemia
    • Taiyuan, Shanxi, China
      Tao Wang
    Feb 9, 2023

    HIV, Leukoencephalopathy, Progressive Multifocal Trial in United States (Filgrastim, Cytarabine, Zidovudine)

    Completed
    • HIV Infections
    • Leukoencephalopathy, Progressive Multifocal
    • Aurora, Colorado
    • +8 more
    Oct 28, 2021

    Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

    Not yet recruiting
    • Acute Myeloid Leukemia With KMT2A Rearrangement
    • Acute Myeloid Leukemia With NPM1 Mutation
    • Biospecimen Collection
    • +7 more
    • (no location specified)
    Jun 1, 2023

    Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in

    Recruiting
    • Acute Myeloid Leukemia
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 7, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • (no location specified)
    Nov 8, 2022

    Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

    Recruiting
    • Myelodysplastic Syndromes
    • Myeloproliferative Chronic Myelomonocytic Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Acute Myeloid Leukemia Trial in United States (Cytarabine, Idarubicin, Daunorubicin)

    Recruiting
    • Acute Myeloid Leukemia
    • Duarte, California
    • +6 more
    Nov 16, 2022

    Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Nov 4, 2022

    Primary CNS Lymphoma (PCNSL) Trial in Zhengzhou (HD-MTX-Ara-C regimen, FTD regimen)

    Completed
    • Primary CNS Lymphoma (PCNSL)
    • HD-MTX-Ara-C regimen
    • FTD regimen
    • Zhengzhou, Henan, China
      Oncology Department of The First Affiliated Hospital of Zhengzho
    Mar 2, 2022

    Diffuse Large Cell Lymphoma Relapsed/Refractory Trial in San Francisco (Ofatumumab, Etoposide, Cytarabine)

    Completed
    Has Results
    • Diffuse Large Cell Lymphoma Relapsed/Refractory
    • San Francisco, California
      University of California, San Francisco
    Jun 5, 2022